Table 1 Patient characteristics between the training and test groups.

From: Prognostic and predictive value of pathohistological features in gastric cancer and identification of SLITRK4 as a potential biomarker for gastric cancer

Characteristics

ALL

Test

Train

p-value

Age

66.75 ± 9.87

68.36 ± 10.16

66.04 ± 9.70

0.078

Gender

1.0

 Female

64(38.79)

19(38.00)

45(39.13)

 

 Male

101(61.21)

31(62.00)

70(60.87)

 

T

0.138

 T1

5(3.03)

3(6.00)

2(1.74)

 

 T2

33(20.00)

14(28.00)

19(16.52)

 

 T3

85(51.52)

22(44.00)

63(54.78)

 

 T4

42(25.45)

11(22.00)

31(26.96)

 

N

0.653

 N0

63(38.18)

20(40.00)

43(37.39)

 

 N1

38(23.03)

13(26.00)

25(21.74)

 

 N2

35(21.21)

11(22.00)

24(20.87)

 

 N3

29(17.58)

6(12.00)

23(20.00)

 

M

0.707

 M0

155(93.94)

48(96.00)

107(93.04)

 

 M1

10(6.06)

2(4.00)

8(6.96)

 

Lauren classification

1.0

 Intestinal type

131(79.39)

40(80.00)

91(79.13)

 

 Diffuse and mixed

34(20.61)

10(20.00)

24(20.87)

 

Location

0.387

 GEJ

99(60.00)

33(66.00)

66(57.39)

 

 NONGEJ

66(40.00)

17(34.00)

49(42.61)

 
  1. T, Tumor; N, Node; M, Metastasis; GEJ, gastroesophageal junction; NONGEJ, Not Gastroesophageal Junction.